Clinical Trial

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain

Study acronym: GEM-1801
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This is an observational, multicentre epidemiological study with a longitudinal cohort in which information will be retrieved from medical records of patients with advanced metastatic or unresectable melanoma at first diagnosis.
Protocol Amendment History 32 amendments
This ClinicalTrials.gov record has been amended 32 times since 2018-07-20; most recent amendment 2025-04-02.
Status change: Not Yet Recruiting → Recruiting 2018-08-08
Trial Details
NCT Number NCT03605771
Lead Sponsor Grupo Español Multidisciplinar de Melanoma
Conditions Melanoma Stage Iv, Melanoma Stage Iii, Advanced Cancer
Enrollment 400 participants
Start Date 2018-08-07
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-04